Please join us for the next H&LS Fireside Founder Chat on Thursday, October 22nd, at 5 pm. Milad Alucozai will be joining us to discuss his journey from founder to venture capital investor. Milad’s journey began when he immigrated to the US as a child, going on to study neuroscience, becoming a successful entrepreneur with a few exits under his belt, to his current work investing in early-stage life science startups. Milad will provide insights into what he looks for in a startup, important traits of successful founders, and how he evaluates early-stage companies as potential investments.
About the Speaker:
Milad Alucozai invests in early-stage life sciences, healthcare, and deep tech companies. He is currently a Partner at Good AI Capital and a Venture Partner at Entrepreneur First, as well as angel investor in seed stage companies. Milad’s career began as a bench scientist working in translational neuroscience and multiphysics labs. He transitioned into becoming a founder and part of the founding team of three different healthcare and life sciences startups. While at Accenture, he led a team of data scientists and engineers to build AI tools and services for large pharmaceutical companies and hospital networks. He is also currently the CBO at Mekonos, a San Francisco based company building a platform for cell delivery supporting the future of cell and gene therapies. Milad’s career spans across North America and Europe helping startups, nonprofits, and large organizations build products that customers love, and helping people unlock their potential and truly thrive. As a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine, he graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed graduate school in Immunology & Public Health.